Along with the high expression of the MYC oncogene that has been shown to promote MM cell survival[30–32], in MM cells carrying the 8p21 deletion, we have observed the upregulated expression of PTK2B (Pyk2 or RAFTK) which was recently demonstrated to promote tumor progression in MM[9]. The gene discussed is MYC; the disease is Miyoshi myopathy.